This article has been updated to clarify details of FDA's letter.

NEW YORK (GenomeWeb) – The US Food and Drug Administration has sent a letter to Sure Genomics asking why the company is marketing its SureDNA sequencing test, which collects and analyzes saliva samples and reports disease risk and drug response information to patients, without its clearance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.